Jeffrey Davis: It’s not contemplated. As you mentioned earlier, we really are very cautious about trying to bake in anything that’s not yet booked. But I would say this is rare, but if all of those deals close, I think that would represent upside to the guidance for the year. Again, that’s probably an unlikely event but it’s possible. But certainly, even without that, I think you’re spot on that it’s going to be more of an indicator and a boost to certainly the latter part of this year but also 2024.
Brian Kinstlinger: Great. And then health care is lower year-over-year and sequentially. You’ve talked about stronger demand in the second half of 2023. And I think you’ve also — at the second half of the year, experienced a large program winding down. So can you share with us for this vertical, are there any indicators of stronger demand trends in health care?
Jeffrey Davis: Yes. We’re seeing — at least for us, we’re seeing certainly positive there — stronger — I don’t know that the demand is that much stronger, but we have finally shed that account that we’ve been talking about. So that account represented over $30 million of revenue in 2021 and was still over $10 million last year. It’s essentially zero now. So we’ve lapped that. And I think we’ll see a growth improvement then in health care. I think that was the biggest drag in health care for us. At the same time — at the same time, I was going to say financial services is growing tremendously fast, which, of course, has a dilutive effect as a percent of revenue on health care.
Operator: Thank you. Our next question comes from the line of Jonathan Lee from Morgan Stanley. Your line is open, Jonathan.
Jonathan Lee: Hi. Thanks for taking my question guys. I wanted to talk through engagement type of pricing just given the macro. Have there been any notable changes to that in the quarter just given what we’re hearing across the macro environment or perhaps shifting of delivery?
Jeffrey Davis: I’m sorry, you’re talking about pricing?
Jonathan Lee: Yes. Like, where are you seeing, if any, notable changes to engagement type or pricing in the quarter, given some of the macro related concerns?
Jeffrey Davis: Other than as we mentioned some actual compression, which is a positive, pricing has been (ph). We’ve actually managed to move ABR up. And again, as I mentioned before, we will be cautious about that, because the whole point of the offshore is to be as competitive as it can on pricing. And we’ve a good pricing power. And I think, as I mentioned in the script, the — and I think Tom alluded to or mentioned as well, that speaks, I think, quite a lot for the value of the clients place on our services. That said, we need to be doing — we’ve got the same skills, same capability, same strength and experience offshore than we do onshore. And we need to be leveraging it more and more, and we are, and that’s where you’re seeing the growth differential.
Jonathan Lee: Got it. And on the hiring front, can you provide an update on what you’re seeing in the hiring market across your geographies? Where are you seeing it’s easier to hire versus tougher to higher?
Jeffrey Davis: I’m going to let Tom just say something real quickly about attrition, and I’ll let Tom take the recruiting question. I think he is talent acquisition. But we mentioned earlier that the attrition rates were well within our range. So the great resignation seems to have moved behind us. So that obviously bodes well for talent acquisition. But I’m going to let Tom comment more specifically on that.
